Does SERTRALINE Cause Second primary malignancy? 7 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Second primary malignancy have been filed in association with SERTRALINE (Sertraline Hydrochloride). This represents 0.0% of all adverse event reports for SERTRALINE.
7
Reports of Second primary malignancy with SERTRALINE
0.0%
of all SERTRALINE reports
0
Deaths
1
Hospitalizations
How Dangerous Is Second primary malignancy From SERTRALINE?
Of the 7 reports, 1 (14.3%) required hospitalization, and 2 (28.6%) were considered life-threatening.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SERTRALINE. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does SERTRALINE Cause?
Drug ineffective (4,439)
Toxicity to various agents (3,110)
Nausea (3,105)
Anxiety (2,981)
Dizziness (2,697)
Headache (2,597)
Intentional overdose (2,540)
Drug interaction (2,504)
Diarrhoea (2,424)
Fatigue (2,349)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which SERTRALINE Alternatives Have Lower Second primary malignancy Risk?
SERTRALINE vs SETMELANOTIDE
SERTRALINE vs SEVELAMER
SERTRALINE vs SEVOFLURANE
SERTRALINE vs SIBUTRAMINE
SERTRALINE vs SILDENAFIL